Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Neuropathologica
Published in: Acta Neuropathologica 6/2010

01-06-2010 | Original Paper

Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease

Authors: Kelly Del Tredici, Christopher H. Hawkes, Estifanos Ghebremedhin, Heiko Braak

Published in: Acta Neuropathologica | Issue 6/2010

Login to get access

Abstract

A retrospective autopsy-based study of the human submandibular gland, one of the three major salivary glands, together with anatomically related peripheral structures (cervical superior ganglion, cervical sympathetic trunk, vagal nerve at the level of the carotid bifurcation), was conducted on a cohort consisting of 33 individuals, including 9 patients with neuropathologically confirmed Parkinson’s disease (PD), three individuals with incidental Lewy body disease (iLBD), 2 individuals with neuropathologically confirmed multiple system atrophy (MSA), and 19 controls, using α-synuclein immunohistochemistry in 100 μm polyethylene glycol-embedded tissue sections. Lewy pathology (LP) was present in the submandibular glands and cervical superior ganglia in PD (9/9 cases) and iLBD (2/3 cases) but not in MSA or controls. The cervical sympathetic trunk (7/9 PD cases, 2/3 iLBD cases) and peripheral vagal nerves (9/9 PD cases, 2/3 iLBD cases) also displayed LP. The results are discussed within the context of hyposmia as well as autonomic dysfunction in PD (sialorrhea, sialopenia, dysphagia). Potential disease-related changes in salivary volume, contents, and viscosity might make it possible, in combination with other tests, to employ human saliva as a biomarker.
Literature
1.
Bagheri H, Damase-Michel C, Lapeyre-Mestre M et al (1999) A study of salivary secretion in Parkinson’s disease. Clin Neuropharmacol 22:213–215PubMed
2.
Baltadzhieva R, Gurevich T, Korczyn AD (2005) Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol 18:487–493CrossRefPubMed
3.
Bassotti G, Germani U, Pagliaricci S et al (1998) Esophageal manometric abnormalities in Parkinson’s disease. Dysphagia 13:28–41CrossRefPubMed
4.
Bateson MC, Gibberd FB, Wilson RSE (1973) Salivary symptoms in Parkinson’s disease. Arch Neurol 29:274–275PubMed
5.
Blessing WW (2004) Lower brain stem regulation of visceral, cardiovascular, and respiratory function. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, London, pp 464–478
6.
Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neurobiol Appl Neurol 32:284–295CrossRef
7.
Boyce HW, Bakheet MR (2005) Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol 39:89–97PubMed
8.
Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed
9.
Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRefPubMed
10.
Braak H, de Vos RAI, Bohl J, Del Tredici K (2006) Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 39:67–72CrossRef
11.
Braak H, Sastre M, Bohl JRE, de Vos RAI, Del Tredici K (2007) Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113:421–429CrossRefPubMed
12.
Bradley RM, Fukami H, Suwabe T (2005) Neurobiology of the gustatory–salivary reflex. Chem Senses 30:i70–i71CrossRefPubMed
13.
Byrne KG, Pfeiffer RM, Quigley EMM (1994) Gastrointestinal dysfunction in Parkinson’s disease: a report of clinical experience at a single center. J Clin Gastroenterol 19:11–16CrossRefPubMed
14.
Cersósimo MG, Benarroch EE (2008) Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 23:1065–1073CrossRefPubMed
15.
Chatoo AH, Lee VM, Linden RA (1953) Evidence for synergism between the masticatory and gustatory parotid salivary reflexes in humans. J Physiol 459:34
16.
Chou KL, Evatt M, Hinson V, Kompoliti K (2007) Sialorrhea in Parkinson’s disease: a review. Mov Disord 22:2306–2313CrossRefPubMed
17.
Cook DI, van Lennep EW, Roberts ML, Young JA (1994) Secretion by the major salivary glands. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 3rd edn. Raven, New York, pp 1061–1117
18.
Crawford JM (1997) The oral cavity and gastrointestinal tract. In: Kumar V, Cotran RS, Robbins SL (eds) Basic pathology. W.B. Saunders, Philadelphia, pp 470–515
19.
Del Tredici K, Rüb U, de Vos RAI, Bohl JRE, Braak H (2002) Where does Parkinson pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426PubMed
20.
den Hartog Jager WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283–290CrossRef
21.
Dickson DW, Fujishiro H, DelleDonne A et al (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease. Acta Neuropathol 115:437–444CrossRefPubMed
22.
Dickson DW, Braak H, Duda JE et al (2009) Diagnostic criteria for the neuropathological assessment of Parkinson disease. Lancet Neurol 8:1150–1157CrossRefPubMed
23.
Doty RL, Deems D, Stellar S (1988) Olfactory dysfunction in Parkinson’s disease: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244PubMed
24.
Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 55:138–142CrossRefPubMed
25.
Edwards LL, Pfeiffer RF, Quigley EMM, Hofman R, Balluff M (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156CrossRefPubMed
26.
Edwards LL, Quigley EM, Harned RK, Hofmann R, Pfeiffer RF (1994) Characterization of swallowing and defecation in Parkinson’s disease. Am J Gastroenterol 1:15–25
27.
Emmelin N (1987) Nerve interactions in salivary glands. J Dent Res 66:509–517PubMed
28.
Evatt ML, Chaudhuri KR, Chou KL et al (2009) Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia, and constipation—critique and recommendations by Movement Disorders Task Force on Rating Scales for Parkinson’s disease. Mov Disord 24:635–646CrossRefPubMed
29.
Forno LS, Norville RL (1976) Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol 34:183–197CrossRefPubMed
30.
31.
Fujishiro H, Frigerio R, Burnett M et al (2008) Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson’s disease. Mov Disord 23:1085–1092CrossRefPubMed
32.
Fumimura Y, Ikemura M, Saito Y et al (2007) Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 66:354–362CrossRefPubMed
33.
Garrett JR (1967) The innervation of normal human submandibular and parotid salivary glands. Arch Oral Biol 12:1417CrossRefPubMed
34.
Garrett JR (1987) The proper role of nerves in salivatory secretion—a review. J Dent Res 66:387–397PubMed
35.
Gerling G, Garrett JR, Paterson KL et al (2008) Innervation and secretory function of transplanted human submandibular salivary glands. Transplantation 85:135–140CrossRef
36.
Ghebremedhin E, Del Tredici K, Langston JW, Braak H (2009) Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson’s disease: an anatomical study. Acta Neuropathol 118:777–784CrossRefPubMed
37.
Giess R, Werner E, Beck M et al (2002) Impaired salivary gland function reveals autonomic dysfunction in amyotrophic lateral sclerosis. J Neurol 249:1246–1249CrossRefPubMed
38.
Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676CrossRefPubMed
39.
Goetz CG, Power W, Rascol O et al (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed
40.
Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST (2002) Orthostatic hypotension from sympathetic denervation in Parkinson’s disease. Neurology 58:1247–1255PubMed
41.
Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 62:436–444CrossRefPubMed
42.
Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844CrossRefPubMed
43.
Hornby PJ, Abrahams TP (2000) Central control of lower esophageal sphincter relaxation. Am J Med 108(Suppl 4):90S–98SCrossRefPubMed
44.
Iwanaga K, Wakabayashi K, Yoshimoto M et al (1999) Lewy body type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases. Neurology 52:1269–1271PubMed
45.
46.
Klosen P, Maessen X, de Aguilar P (1993) PEG embedding for immunocytochemistry: application to the analysis of immunoreactivity loss during histological processing. J Histochem Cytochem 41:455–463PubMed
47.
Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241–1253PubMed
48.
Kyriacou K, Garrett JR (1988) Morphological changes in the rabbit submandibular gland after parasympathetic or sympathetic denervation. Arch Oral Biol 33:281–290CrossRefPubMed
49.
Leopold NA, Kagel MC (1995) Prepharyngeal dysphagia in Parkinson’s disease. Dysphagia 11:14–22CrossRef
50.
Leopold NA, Kagel MC (1997) Pharyngo-esophageal dysphagia in Parkinson’s disease. Dysphagia 12:11–18CrossRefPubMed
51.
52.
Markesbery WR, Jicha GA, Liu H, Schmitt FA (2009) Lewy body pathology in normal elderly subjects. J Neuropathol Exp Neurol 68:816–822CrossRefPubMed
53.
Martinez-Madrigal F, Micheau C (1989) Histology of the major salivary glands. Am J Surg Pathol 13:879–899PubMedCrossRef
54.
Martinez-Marin P, Schapira AHV, Stocchi F et al (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting: study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 23:1623–1629CrossRef
55.
McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872CrossRefPubMed
56.
Miki Y, Mori F, Wakabayashi K, Kuroda N, Orimo S (2009) Incidental Lewy body disease restricted to the heart and stellate ganglion. Mov Disord 24:2299–2301CrossRefPubMed
57.
Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F et al (2007) Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study. Neurology 68:2012–2018CrossRefPubMed
58.
Nishie M, Mori F, Yoshimoto M, Takahashi H, Wakabayashi K (2004) A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 30:546–554CrossRefPubMed
59.
Orimo S, Takahashi A, Uchihara T et al (2007) Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson’s disease. Brain Pathol 17:24–30CrossRefPubMed
60.
Orimo S, Uchihara T, Nakamura A et al (2008) Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson’s disease. Brain 131:642–650CrossRefPubMed
61.
Pfeiffer RF (1998) Gastrointestinal dysfunction in Parkinson’s disease. Clin Neurosci 5:136–146PubMed
62.
Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 2:107–116CrossRefPubMed
63.
Probst A, Bloch A, Tolnay M (2008) New insights into the pathology of Parkinson’s disease: does the peripheral autonomic nervous system become central? Eur J Neurol 15(Suppl 1):1–4CrossRefPubMed
64.
Proctor GB, Carpenter GH (2007) Regulation of salivary gland function by autonomic nerves. Auton Neurosci Basic Clin 133:3–18CrossRef
65.
Proulx M, de Courval FP, Wiseman MA, Panisset M (2005) Salivary production in Parkinson’s disease. Mov Disord 20:204–207CrossRefPubMed
66.
Qualman SJ, Haupt HM, Yang P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson’s disease. Gastroenterology 87:848–856PubMed
67.
Richards WG, Sugarbaker DJ (1995) Neuronal control of esophageal function. Chest Surg Clin North Am 5:157–171
68.
Robbins JA, Logemann JA, Kirshner HS (1986) Swallowing and speech production in Parkinson’s disease. Ann Neurol 19:283–287CrossRefPubMed
69.
Ross GW, Petrovitch H, Abbott RD et al (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21:2062–2067CrossRefPubMed
70.
Schwab RS, England AS (1958) Parkinson’s disease. J Chronic Dis 8:448–501CrossRef
71.
Shannon IL, Suddick RP, Chauncey HH (1969) Effect of atropine-induced flow rate depression on composition of unstimulated human parotid fluid. Arch Oral Biol 14:761–770CrossRefPubMed
72.
Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF (2002) Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey. Parkinsonism Rel Disord 8:277–284CrossRef
73.
74.
Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G (2005) α-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol 110:19–26CrossRefPubMed
75.
Takeda S, Yamazaki K, Miyakawa T, Arai H (1993) Parkinson’s disease with involvement of the parasympathetic ganglia. Acta Neuropathol 86:397–398CrossRefPubMed
76.
Taki J, Nakajima K, Hwang EH et al (2000) Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27:566–573CrossRefPubMed
77.
Tissingh G, Berendse HW, Bergmanns P et al (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 16:41–46CrossRefPubMed
78.
Tumilasci OR, Cersósimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH (2006) Quantitative study of salivary secretion in Parkinson’s disease. Mov Disord 21:660–667CrossRefPubMed
79.
Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ (2007) Patient-reported autonomic symptoms in Parkinson’s disease. Neurology 69:333–341CrossRefPubMed
80.
Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76:217–221CrossRefPubMed
81.
Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1990) Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79:581–583CrossRefPubMed
82.
Wakabayashi K, Takahashi H, Obata K, Ikuta F (1992) Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson’s disease. Neurosci Lett 138:237–240CrossRefPubMed
83.
Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F (1993) Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease. Adv Neurol 60:609–612PubMed
Metadata
Title
Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease
Authors
Kelly Del Tredici
Christopher H. Hawkes
Estifanos Ghebremedhin
Heiko Braak
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 6/2010
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-010-0665-2

Other articles of this Issue 6/2010

Acta Neuropathologica 6/2010 Go to the issue

Original Paper

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

Original Paper

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

Original Paper

The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes

Review

Papp–Lantos inclusions and the pathogenesis of multiple system atrophy: an update

Original Paper

CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy

Case Report

Human lissencephaly with cerebellar hypoplasia due to mutations in TUBA1A: expansion of the foetal neuropathological phenotype